Quantcast

Latest Management of cancer Stories

Ultra-sensitive Nano-chip For Early Cancer Detection
2014-05-19 03:57:21

[ Watch The Video: A New Method For Early Cancer Detection ] ICFO-The Institute of Photonic Sciences Today, the majority of cancers are detected on the macroscopic level, when the tumor is already composed of millions of cancer cells and the disease is starting to advance into a more mature phase. But what if we could diagnose cancer before it took hold- while it was still only affecting a few localized cells? It would be like putting a fire out while it was still just a few sparks...

2014-05-16 16:24:58

Oncotype DX® Prostate Cancer Test Enables More Precise Risk Assessment and Significantly Increases Number of Low-Risk Patients Who Can Confidently Choose Active Surveillance REDWOOD CITY, Calif., May 16, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) announced today that groundbreaking results from three studies of the Oncotype DX(®) prostate cancer test were published in European Urology. The peer-reviewed publication highlights studies that focus on addressing the need...

2014-05-14 08:31:42

SAN DIEGO, May 14, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (OTCQB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce. http://photos.prnewswire.com/prnvar/20090325/LA88762LOGO-b The discovery that our Hemopurifer® captures tumor-secreted exosomes provides hope for a new therapeutic paradigm to augment cancer care. Yes, the same Hemopurifier® we are preparing to advance in a forthcoming FDA approved infectious disease study. In my last CEO note, I...

2014-05-09 19:06:35

Massachusetts Institute of Technology Nanoparticles that stagger delivery of 2 drugs knock out aggressive tumors in mice MIT researchers have devised a novel cancer treatment that destroys tumor cells by first disarming their defenses, then hitting them with a lethal dose of DNA damage. In studies with mice, the research team showed that this one-two punch, which relies on a nanoparticle that carries two drugs and releases them at different times, dramatically shrinks lung and breast...

2014-05-07 23:09:14

Survey results published today, by a Tampa Bay medical device manufacturer, BioDerm, reveal a surprising connection between music and patient’s perceptions of the side effects of prostate cancer treatment. Largo, FL (PRWEB) May 07, 2014 In a survey of more than 200 men with prostate cancer and their caregivers, BioDerm found that opera fans were more than 40% more likely than non-opera fans to report that their side effects after prostate cancer treatment were “worse” or “much...

2014-05-07 08:33:48

LOS ANGELES, May 7, 2014 /PRNewswire/ -- Skin doctor, Dr. Peyman Ghasri, offers a variety of treatments for different types of skin cancer at Castle Dermatology. Skin cancer is the most common type of cancer in the country today with more than two million people diagnosed every year. The three most common types of skin cancer are Squamous skin cancer, Basal Cell skin cancer and Melanoma skin cancer. Treatment can vary based on the type of cancer, the extent of the cancer, the...

2014-05-06 16:33:11

Hope Summit and New Scientific Grant Applications Kick Off Lung Cancer Hope Month WASHINGTON, May 6, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer nonprofit, commemorates May, Lung Cancer Hope Month, as a time to celebrate the hope and promise of science in the ongoing quest for a world where no one dies from lung cancer. LUNGevity Foundation President and CEO Andrea Stern Ferris noted the remarkable progress in lung cancer treatments, growth of lung...

2014-05-05 08:28:31

New Data Include Results on Oncotype DX's Prognosis of Late Recurrence in Invasive Breast Cancer and Clinical Utility in Ductal Carcinoma In Situ (DCIS) REDWOOD CITY, Calif., May 5, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from nine studies of Oncotype DX(®) in breast, colon, prostate and renal cancer will be presented at the American Society of Clinical Oncology(®) (ASCO(®)) Annual Meeting, taking place May 30 - June 3, 2014 at McCormick Place...

2014-05-02 08:25:16

Large Study Published in The Oncologist Underscores Test's Value in Guiding Treatment Decisions REDWOOD CITY, Calif., May 2, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that The Oncologist published positive results from an Oncotype DX(®) colon cancer decision impact study, demonstrating that Recurrence Score(®) results changed treatment recommendations in 45 percent of stage II colon cancer patients. The study was conducted in collaboration with the...

2014-05-01 23:07:27

Cianna Medical: Early-stage breast cancer treatment enables more women to opt for partial breast radiation. Aliso Viejo, CA (PRWEB) May 01, 2014 Cianna Medical, Inc., a women’s health company, today announced the results of a trial examining the long-term side effects of strut-based brachytherapy for early-stage breast cancer. According to researchers, treatment with SAVI® breast brachytherapy resulted in very low rates of late toxicities, even in patients with minimal space...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.